However, a study in 344 pediatric cancer patients (mostly with leukemias and lymphomas) of mixed ethnicity (Canada) described an association between the G allele of the SLC22A7 rs4149178 SNP and a lower risk of cardiotoxicity during anthracycline treatment [56]. The gene discussed is SLC22A7; the disease is cancer.